Diabetes-induced central cholinergic neuronal loss and cognitive deficit are attenuated by tacrine and a Chinese herbal prescription, Kangen-karyu: Elucidation in type 2 diabetes db/db mice

Journal of Pharmacological Sciences

Volumn 117, Issue 4, 2011, Pages 230-242

  Zhao, Qi ^a   Matsumoto, Kinzo ^a   Tsuneyama, Koichi ^b   Tanaka, Ken ^a   Li, Feng ^a   Shibahara, Naotoshi ^a   Miyata, Takeshi ^a,c   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c SOJO UNIVERSITY   (Japan)

Author keywords

Brain derived neurotrophic factor (BDNF); Cholinergic system; Dementia; Diabetic; Kangen karyu

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE ACETYLTRANSFERASE; GLUCOSE; HERBACEOUS AGENT; KANGEN KARYU EXTRACT; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M5 RECEPTOR; TACRINE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG MECHANISM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; MALE; MAZE TEST; MENTAL PERFORMANCE; MOUSE; NERVE CELL DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION;

EID: 84862946286     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11115FP     Document Type: Article

References (47)

1. Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221:555-563.
2. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm. 2006;13:1625-1644. (Pubitemid 44657659)
3. Bartus RT. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol. 2000;163: 495-529. (Pubitemid 30399100)
4. Zhao Q, Murakami Y, Tohda M, Obi R, Shimada Y, Matsumoto K. Chotosan, a Kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition. J Pharmacol Sci. 2007;103:360-373. (Pubitemid 46640689)
5. Yamada M, Hayashida M, Zhao Q, Shibahara N, Tanaka K, Miyata T, et al. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice. J Ethnopharmacol. 2011;135:737-746.
6. Murakami Y, Zhao Q, Harada K, Tohda M, Watanabe H, Matsumoto K. Choto-san, a Kamp formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacol Biochem Behav. 2005;81:616-625. (Pubitemid 40966810)
7. Ni JW, Matsumoto K, Li HB, Murakami Y, Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res. 1995;673:290-296.
8. Zhao WQ, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim Biophys Acta. 2009;1792:482-496.
9. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004;53:474-481. (Pubitemid 38174565)
10. Brennan AM, Mantzoros CS. Drug insight: the role of leptin in human physiology and pathophysiology - emerging clinical applications. Nat Clin Pract Endocrinol Metab. 2006;2:318-327. (Pubitemid 43885911)
11. Takahashi M, Sugaya K, Kubota K. Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion. Jpn J Pharmacol. 1992;60:307-310. (Pubitemid 23009069)
12. Makino T, Wakushima H, Okaoto T, Okubo Y, Saito K, Kano Y. Effects of Kangen-karyu on coagulation system and platelet aggregation in mice. Biol Pharm Bull. 2002;25:523-525. (Pubitemid 40036747)
13. Gao M, Ikeda K, Mori K, Yamori Y. [Studies on preventive effect of "Kangenkaryu", Chinese herbal medicine, on stroke in SHRSP.] J Trad Med. 2001;18:245-250. (text in Japanese with English abstract)
14. Yamabe N, Kim HY, Kang KS, Zhao Q, Matsumoto K, Yokozawa T. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice. J Ethnopharmacol. 2010; 129:299-305.
15. Pu F, Motohashi K, Kaneko T, Tanaka Y, Manome N, Irie K, et al. Neuroprotective effects of Kangen-karyu on spatial memory impairment in an 8-arm radial maze and neuronal death in the hippocampal CA1 region induced by repeated cerebral ischemia in rats. J Pharmacol Sci. 2009;109:424-430.
16. Zhao Q, Yokozawa T, Yamabe N, Tsuneyama K, Li X-H, Matsumoto K. Kangen-karyu improves memory deficit caused by aging through normalization of neuroplasticity-related signaling system and VEGF system in the brain. J Ethnopharmacol. 2010;131:377-385.
17. Noh JS, Park CH, Kim HY, Zhao Q, Yamabe N, Matsumoto K, et al. Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes. J Pharm Pharmacol. 2011;63:111-119.
18. Yokozawa T, Kim Y-A, Kim H-Y, Okamoto T, Sei Y. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells. J Ethnopharmacol. 2007;109:113-120. (Pubitemid 44821678)
19. Horai H, Arita M, Kanaya S, Nihei Y, Ikeda T, Suwa K, et al. MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom. 2010;45:703-714.
20. Zhao Q, Murakami Y, Tohda M, Watanabe H, Matsumoto K. Preventive effect of chotosan, a Kampo medicine, on transient ischemia-induced learning deficit is mediated by stimulation of muscarinic M1 but not nicotinic receptor. Biol Pharm Bull. 2005;28:1873-1878. (Pubitemid 41437073)
21. Cui H-S, Murakami Y, Hori H, Zhao Q, Obi R, Matsumoto K. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of Bcl-2 phosphorylation suppression. Biol Pharm Bull. 2009;32:79-85.
22. Curran-Everett D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society: the sequel. Adv Physiol Educ. 2007;31:295-298.
23. Sharma AN, Elased KM, Garrett TL, Lucot JB. Neurobehavioral deficits in db/db diabetic mice. Physiol Behav. 2010;101: 381-388.
24. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998;800:125-135. (Pubitemid 28361929)
25. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002;113:607-615. (Pubitemid 34874684)
26. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nature Neurosci. 2008;11:309-317. (Pubitemid 351311802)
27. Oomura Y, Aou S, Fukunaga K. Prandial increase of leptin in the brain activates spatial learning and memory. Pathophysiology. 2010;17:119-127.
28. Vaynman S, Ying Z, Pinilla FG. The select action of hippocampal calcium calmodulin protein kinase II in mediating exercise-enhanced cognitive function. Neuroscience. 2007;144:825-833. (Pubitemid 46013982)
29. Zhao H-F, Li Q, Zhang Z-F, Pei X-R, Wang J, Li Y. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res. 2009;1256: 111-122.
30. Komulainen P, Pedersen M, Hanninen T, Bruunsgaard H, Lakka TA, Kivipelto M, et al. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem. 2008;90:596-603.
31. Hartig W, Bauer A, Brauer K, Grosche J, Hortobagyi T, Penke B, et al. Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions? Rev Neurosci. 2002;13:95-165.
32. Fornari RV, Moreira KM, Oliveira MGM. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem. 2000;7:287-292.
33. Volpicelli LA, Leve AI. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res. 2004;145:59-66. (Pubitemid 37442934)
34. Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, Saido TC, et al. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis. 2006;24:334-344. (Pubitemid 44572752)
35. Poulin B, Butcher A, McWilliams P, Bourgognon JM, Pawlak R, Kong KC, et al. The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner. Proc Natl Acad Sci U S A. 2010;107:9440-9445.
36. Tanaka K, Mizukawa K, Ogawa N, Mori A. Post-ischemic administration of the acetylcholinesterase inhibitor ENA-713 prevents delayed neuronal death in the gerbil hippocampus. Neurochem Res. 1995;20:663-667.
37. Tanaka K, Ogawa N, Asanuma M, Hirata H, Kondo Y, Nakayama N, et al. Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain. Arch Int Pharmacodyn Ther. 1993; 323:85-96. (Pubitemid 23287115)
38. Yang B, Lin H, Xu C, Liu Y, Wang H, Han H, et al. Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem. 2005;16:163-174. (Pubitemid 41643017)
39. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nature Genet. 2004;36:827-835. (Pubitemid 39014099)
40. Plaschke K, Staub J, Ernst E, Marti HH. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol. 2008;214:285-292.
41. Ohta H, Matsumoto K, Shimizu M, Watanabe H. Paeoniflorin attenuates learning impairment of aged rats in operant brightness discrimination task. Pharmacol Biochem Behav. 1994;49:213-217. (Pubitemid 24297279)
42. Ohta H, Ni J-W, Matsumoto K, Watanabe H, Shimizu M. Peony and its major constituent, paeoniflorin, improve radial maze performance impaired by scopolamine in rats. Pharmacol Biochem Behav. 1993;45:719-723.
43. Imanshahidi M, Hosseinzadeh H. The pharmacological effects of Salvia species on the central nervous system. Phytotherapy Res. 2006;20:427-437. (Pubitemid 43953393)
44. Kim D-H, Jeon SJ, Jung JW, Lee S-J, Yoon BY, Shin BY, et al. Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance task in mice. Eur J Pharmacol. 2007;574:140-147. (Pubitemid 47592846)
45. Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25-35. Behav Brain Res. 2007;180:139-145. (Pubitemid 46719420)
46. Pereira P, Tysca D, Oliveira P, da Silva Brum LF. Neurobehavioral and genotoxic aspects of rosmarinic acid. Pharmacol Res. 2005;52:199-203. (Pubitemid 40981918)
47. Nomura Y, Arima T, Namba T, Hattori M, Kadota S. [Ameliorating effects of dan-shen and its major ingredient calcium/magnesium lithospermate B on cognitive deficiencies in senescence-accelerated mouse]. Folia Pharmacol Jpn (Nihon Yakurigaku Zasshi). 1997;110 Suppl 1:142P-147P. (text in Japanese with English abstract)